Relay Medical Announces Extension of Warrant Expiry Dates
Toronto, Ontario--(Newsfile Corp. - November 5, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, announces that it intends to extend the expiry date of an aggregate of 7,662,500 previously issued warrants on May 17, 2019 (the "May Warrants") at an exercise price of $0.30 for an additional ninety (90) days, being February 15, 2021. In addition, the Company announces that it intends to extend the expiry date...
2020-11-05 3:38 PM EST
Relay Medical Forms Clinical and Strategic Advisory Boards
Toronto, Ontario--(Newsfile Corp. - September 22, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") , a developer of MedTech innovation, is pleased to report on the formation of a Clinical Advisory Board of multi-disciplined experts and a Strategic Advisory Board to guide the Company on regulation, finance, and commercial strategies in the healthtech sector. The Company is also pleased to announce initial appointments to both boards consisting of...
2020-09-22 2:50 AM EDT
Relay Medical Announces Closing of Private Placement for Gross Proceeds of Over $1,800,000
Toronto, Ontario--(Newsfile Corp. - September 17, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), is pleased to announce the closing of a non-brokered private placement financing (the "Offering") of gross proceeds of $1,833,316.02 through the issuance of 10,185,089 units (each, a "Unit") at a price of $0.18 per Unit. Each Unit is comprised of: (i) one common share in the capital of the Company (each a "Common Share"); (ii) one Common...
2020-09-17 5:18 PM EDT
Relay Medical and Fio Corporation Announce Joint Venture for Pandemic Testing Technology
Toronto, Ontario--(Newsfile Corp. - August 19, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), and Fio Corporation ("Fio") are pleased to announce the establishment of a joint venture ("JV") to accelerate adaption and delivery of Fio's proven data-and-device platform, Fionet, as a COVID-19 pandemic testing, data collection and reporting solution. The JV will operate under the name "Fionet Rapid Response Group" and be headquartered in Toronto,...
2020-08-19 3:00 AM EDT
Relay Medical and Fio Corporation Extend MOU Agreement for Collaboration on a Rapid Diagnostic Testing Platform
Toronto, Ontario--(Newsfile Corp. - August 16, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), and Fio Corporation ("Fio") jointly report that the Companies have extended the memorandum of understanding ("MOU" or the "Agreement") previously announced on May 15, 2020 and extended on July 19, 2020.The MOU Agreement has been extended for 7 days with an expiry of August 22, 2020.Under the terms of the agreement Relay will provide expertise in medical...
2020-08-16 8:49 PM EDT
Relay Medical Teams Up with HaloHealth Angel Network; Initiating a Strategic and Collaborative Partnership
Toronto, Ontario--(Newsfile Corp. - August 7, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to report on a strategic partnership with HaloHealth Angel Network.HaloHealth1 is Canada's first angel network for healthcare and their mission is simple- wanting to help Canada's early stage medical companies succeed and grow by connecting them with domain expertise and capital investment from their...
2020-08-07 7:30 AM EDT
Relay Medical and Fio Corporation Extend MOU Agreement for Collaboration on a Rapid Diagnostic Testing Platform
Toronto, Ontario--(Newsfile Corp. - July 20, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), and Fio Corporation ("Fio") jointly report that the Companies have extended the memorandum of understanding ("MOU" or the "Agreement") previously announced on May 15, 2020.The MOU Agreement has been extended for 30 days with an expiry of August 15, 2020.Under the terms of the agreement Relay will provide expertise in medical technology development and...
2020-07-20 8:55 AM EDT
Relay Medical Announces Closing of Private Placement for Proceeds of Over $600,000
Toronto, Ontario--(Newsfile Corp. - May 29, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), is pleased to announce the closing of a non-brokered private placement financing (the "Offering") of gross proceeds of $639,500 through the issuance of 3,522,777 Units (each, a "Unit") at a price of $0.18 per Unit. Each Unit is comprised of: (i) one common share in the capital of the Company (each a "Common Share"); (ii) one Common Share...
2020-05-29 5:35 PM EDT
Relay Medical and Fio Corporation Announce the Signing of MOU Agreement to Collaborate on a Rapid Diagnostic Testing Platform
Toronto, Ontario--(Newsfile Corp. - May 15, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), and Fio Corporation ("Fio") are pleased to announce the signing of a memorandum of understanding ("MOU" or the "Agreement") to define a mutually beneficial collaboration to accelerate the enhancement of Fio's Data-Device Platform as a COVID-19 testing, data collection and reporting platform. Under the terms of the agreement Relay will provide expertise in...
2020-05-15 4:05 PM EDT
Relay Medical Reports on Pharmatrac Development and Commercialization; Files Trademark, Launches Website, Showcases Technology and Telemedicine Applications to Serve Patients At-Home Around the Globe
Toronto, Ontario--(Newsfile Corp. - May 5, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to provide a comprehensive update on development and commercialization activities related to its wholly owned PharmatracTM Medication System.HighlightsUser Studies - Cliantha Research engaged to support next phase of Pharmatrac user studies3D Gestures - Relay completes proof-of-principle prototype with motion...
2020-05-05 4:31 PM EDT
Relay Medical and Swiss PharmaCan AG Appoint Former Nestle Brand Manager and Leafly Marketing Director as Chief Commercial Officer of Glow LifeTech
Toronto, Ontario--(Newsfile Corp. - April 27, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, and Swiss PharmaCan AG, an award-winning European bio-tech company, are pleased to announce the appointment of Marketing Executive Rob Carducci as Chief Commercial Officer (CCO) of Glow LifeTech Ltd. Mr. Carducci's appointment takes effect immediately.Robert Carducci is a seasoned marketing executive with over a decade...
2020-04-27 4:05 PM EDT
Relay Medical Provides Update on the Role of CO-oximetry Technology in Nitric Oxide Therapy for COVID-19
Toronto, Ontario--(Newsfile Corp. - April 22, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to provide an update on the role of CO-oximetry measurements in nitric oxide therapy which are being investigated to treat COVID-19 patients. Relay is currently developing the HemoPalm-CX, a portable analyzer that provides a full panel of CO-oximetry results including total Hemoglobin (tHb), oxyhemoglobin...
2020-04-22 4:15 PM EDT
Relay Medical and Swiss PharmaCan AG Announce Initial Glow LifeTech Product Line
Toronto, Ontario--(Newsfile Corp. - April 16, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, and Swiss PharmaCan AG, an award-winning European bio-tech company, are pleased to provide an update on the Glow LifeTech ("Glow") Joint-Venture Subsidiary and initial product line.In early March, Relay Medical announced the signing of an agreement whereby Glow LifeTech Ltd. would acquire the exclusive North American...
2020-04-16 4:05 PM EDT
Relay Medical Provides Update on HemoPalm Cybersecurity; Partners with Cybeats Technologies Inc.
Toronto, Ontario--(Newsfile Corp. - April 8, 2020) - Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to provide an update on cybersecurity protection on its HemoPalm Corp. devices and the collaboration with world-class cybersecurity company Cybeats Technologies Inc. The HemoPalm device suite is being developed to bring Point-of-Care (POCT) critical diagnostics analyses to the forefront of patient care, which...
2020-04-08 4:05 PM EDT
Relay Medical Announces Completion of Pharmatrac API Development; Now Able to Service Telemedicine Platforms and Medication Management Applications
Toronto, Ontario--(Newsfile Corp. - March 5, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce the development of an application programing interface (API) for its Pharmatrac Medication Management System. With this development the Company is now poised for strategic integration with partners in the telemedicine and medication management markets.The Pharmatrac API allows 3rd party mobile...
2020-03-05 4:05 PM EST
Relay Medical Announces Subsidiary Glow LifeTech has Secured Exclusive Rights for Award Winning Swiss Technology for All-Natural Rapid Onset and Enhanced Potency Nutraceutical and Cannabis Products
Toronto, Ontario--(Newsfile Corp. - March 2, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, provides an update on Glow LifeTech Ltd. subsidiary and corporate expansion activities. In December 2018, Relay announced the formation of Glow LifeTech Ltd. ("Glow"), a subsidiary to explore technology opportunities in the global cannabis sector. Relay Medical is pleased to announce that its Glow LifeTech subsidiary has...
2020-03-02 3:00 AM EST
Relay Medical announces Provisional Patent for POCT CO-oximetry Technology; Launches HemoPalm website in Mandarin
Toronto, Ontario--(Newsfile Corp. - February 27, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce the filing of a provisional patent entitled Precision Optical Chambers Device, System, and Method of Manufacturing Same, for its HemoPalm-CX Point-of-Care Testing (POCT) CO-Oximetry device.The patent's main claims cover the single-use blood sample cuvette designed to be used with the...
2020-02-27 4:05 PM EST
Relay Medical announces completion of HemoPalm(TM) Proof-of-Principle CO-oximeter Prototype, a Proprietary, State-of-the-Art, Point-of-Care Technology
Toronto, Ontario--(Newsfile Corp. - February 25, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") , a developer of MedTech innovation, is pleased to announce the completion of the HemoPalm-CX™, a proof-of-principle prototype compact POCT instrument that directly measures five CO-oximetry components from human whole blood. The system uses proprietary optics and data analysis technology developed by the Company's HemoPalm diagnostics division.Relay's...
2020-02-25 4:05 PM EST
Relay Medical Files Patent on Pharmatrac System Countertop Medication Device
Toronto, Ontario--(Newsfile Corp. - February 20, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce the filing of a patent entitled Clustering Station, System, and Method for Alert Scheduling, for its Pharmatrac System. The patent is now pending in 153 countries and regions around the world. The patent's main claims cover the Pharmatrac System's counter-top medication device that has been...
2020-02-20 4:16 PM EST
Relay Medical Presents Pharmatrac Countertop Medication Device; Provides Development Update
Toronto, Ontario--(Newsfile Corp. - February 18, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine for MedTech innovation, is pleased to provide an update on Pharmatrac development activities and present the Pharmatrac Countertop Medication Device.The Pharmatrac System is being developed to offer sophisticated solutions to improve medication management for patients, caregivers and other stakeholders in the healthcare environment. The...
2020-02-18 4:05 PM EST